- Recent Funding
- Investors
- North China Pharmaceutical Group Corporation
North China Pharmaceutical Group Corporation portfolio
North China Pharmaceutical Group Corporation has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Anyuan Pharmaceuticals's $33.02M funding round in October 2026, which it led. That company is in Health and bio.
What North China Pharmaceutical Group Corporation invests in
- Health and bio · 1 · 100%
How North China Pharmaceutical Group Corporation invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| round | 1 100% | $33.02M |
North China Pharmaceutical Group Corporation portfolio companies
AAnyuan Pharmaceuticals$33.02Mround · Oct 2026
| Company | Round with North China Pharmaceutical Group Corporation | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
round · $33.02M · lead | $33.02M | Oct 29, 2026 round |
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name North China Pharmaceutical Group Corporation. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists North China Pharmaceutical Group Corporation, which is a subset of its real portfolio. API: /api/v1/investors/north-china-pharmaceutical-group-corporation (get a free API key). More: the most active VC firms and new venture capital funds.